400 related articles for article (PubMed ID: 30663009)
1. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis.
Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009
[TBL] [Abstract][Full Text] [Related]
2. Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury.
Ishimura S; Furuhashi M; Mita T; Fuseya T; Watanabe Y; Hoshina K; Kokubu N; Inoue K; Yoshida H; Miura T
Sci Rep; 2014 Nov; 4():6943. PubMed ID: 25373918
[TBL] [Abstract][Full Text] [Related]
3. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
4. Phloretin Inhibits Platelet-derived Growth Factor-BB-induced Rat Aortic Smooth Muscle Cell Proliferation, Migration, and Neointimal Formation After Carotid Injury.
Wang D; Wang Q; Yan G; Qiao Y; Tang C
J Cardiovasc Pharmacol; 2015 May; 65(5):444-55. PubMed ID: 25945863
[TBL] [Abstract][Full Text] [Related]
5. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
6. [Effects of rosuvastatin in homocysteine induced mouse vascular smooth muscle cell dedifferentiation and endoplasmic reticulum stress and its mechanisms].
Zhou CZ; Pan SL; Lin H; Meng LP; Ji Z; Chi JF; Guo HY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):43-48. PubMed ID: 29926658
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
Huang C; Zhang W; Zhu Y
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
[TBL] [Abstract][Full Text] [Related]
8. Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice.
Zhu L; Hao Y; Guan H; Cui C; Tian S; Yang D; Wang X; Zhang S; Wang L; Jiang H
Mol Cell Biochem; 2013 Jan; 373(1-2):53-62. PubMed ID: 23065380
[TBL] [Abstract][Full Text] [Related]
9. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
[TBL] [Abstract][Full Text] [Related]
10. Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor-β.
Shao W; Li X; Peng J; Fan S; Liang M; Huang K
J Cell Mol Med; 2020 Sep; 24(17):10128-10139. PubMed ID: 32697395
[TBL] [Abstract][Full Text] [Related]
11. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
12. A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia.
Serrano RL; Yu W; Graham RM; Bryan RL; Terkeltaub R
PLoS One; 2019; 14(4):e0212235. PubMed ID: 30943188
[TBL] [Abstract][Full Text] [Related]
13. Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
Huang C; Zhao J; Zhu Y
J Am Heart Assoc; 2020 Jan; 9(1):e014103. PubMed ID: 31880978
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
[TBL] [Abstract][Full Text] [Related]
15. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
16. M2 macrophage-derived exosomes promote the c-KIT phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation.
Yan W; Li T; Yin T; Hou Z; Qu K; Wang N; Durkan C; Dong L; Qiu J; Gregersen H; Wang G
Theranostics; 2020; 10(23):10712-10728. PubMed ID: 32929376
[No Abstract] [Full Text] [Related]
17. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the cerebrovascular smooth muscle cell phenotype by mitochondrial oxidative injury and endoplasmic reticulum stress in simulated microgravity rats via the PERK-eIF2α-ATF4-CHOP pathway.
Zhang R; Jiang M; Zhang J; Qiu Y; Li D; Li S; Liu J; Liu C; Fang Z; Cao F
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165799. PubMed ID: 32304741
[TBL] [Abstract][Full Text] [Related]
19. Suppression of endoplasmic reticulum stress improves endothelium-dependent contractile responses in aorta of the spontaneously hypertensive rat.
Spitler KM; Matsumoto T; Webb RC
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H344-53. PubMed ID: 23709602
[TBL] [Abstract][Full Text] [Related]
20. RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling.
Huang C; Zhou M; Zheng X
J Vasc Surg; 2019 May; 69(5):1581-1589.e1. PubMed ID: 31010523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
